Chemours (CC) Receivables (2014 - 2026)

Chemours has reported Receivables for 13 years, with the latest figure at $957.0 million in Q2 2026.

• On a quarterly basis, Receivables fell 5.15% year-over-year to $957.0 million in Q2 2026; TTM through Jun 2026 was $957.0 million, a 5.15% decrease from a year earlier, with the FY2025 full-year figure at $729.0 million, down 11.1% from the prior year.
• Receivables was $957.0 million for Q2 2026 at Chemours, up from $809.0 million in the prior quarter.
• The five-year high for Receivables was $1.2 billion in Q2 2022, with the low at $622.0 million in Q4 2023.
• Average Receivables over 5 years is $914.3 million, with a median of $932.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Receivables soared 52.19% in 2022, then fell 17.19% in 2023.
• Over 5 years, Receivables stood at $726.0 million in 2022, then retreated by 14.33% to $622.0 million in 2023, then soared by 31.83% to $820.0 million in 2024, then decreased by 11.1% to $729.0 million in 2025, then surged by 31.28% to $957.0 million in 2026.
• The last three Receivables figures came in at $957.0 million (Q2 2026), $809.0 million (Q1 2026), and $729.0 million (Q4 2025), per Business Quant data.